Curaleaf (OTCMKTS:CURLF) Sees Strong Trading Volume – Time to Buy?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) saw an uptick in trading volume on Wednesday . 2,098,109 shares were traded during mid-day trading, an increase of 139% from the previous session’s volume of 878,029 shares.The stock last traded at $3.86 and had previously closed at $3.03.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Curaleaf from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Curaleaf has an average rating of “Buy”.

Curaleaf Stock Performance

The company’s fifty day moving average is $2.41 and its 200 day moving average is $2.59. The company has a market capitalization of $2.27 billion, a P/E ratio of -11.00 and a beta of 0.77. The company has a current ratio of 1.52, a quick ratio of 0.76 and a debt-to-equity ratio of 1.14.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company had revenue of $333.07 million during the quarter, compared to the consensus estimate of $328.70 million. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%. As a group, equities analysts anticipate that Curaleaf Holdings, Inc. will post -0.28 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.